Enzo Biochem reports Q2 revenue $7.3M vs. $6.2M in Q1

Reports Q2 revenue of $7.3M increased sequentially by $1.1M from $6.2M. This is an improvement of 18%. Year-over-year quarterly period revenue declined by 14% primarily from the timing of large order fulfillment and the market slowdown in the US.Enzo ended the second quarter with aggregate cash and cash equivalents of $40.3 million. The Board of Directors and management continue to be focused on conserving cash.